| Glatiramer acetate inhibits the activation of NFκB in the CNS of experimental autoimmune encephalomyelitis |
|
Insun Hwang, Danbee Ha, Dae Seung Kim, Haejin Joo, Youngheun Jee |
|
College of Veterinary Medicine, Jeju National University |
| Glatiramer acetate 투여에 의한 자가면역성 뇌척수염 마우스의 중추신경계에서의 NFκB 활성 억제 |
|
황인선, 하단비, 김대승, 주해진, 지영흔 |
|
제주대학교 수의과대학 수의학과 |
|
|
| Abstract |
|
Glatiramer acetate (GA; Copaxone) has been shown to be effective in preventing and suppressing experimental autoimmune encephalomyelitis (EAE), the animal model of multiple sclerosis (MS). It has been recently shown that GA-reactive T cells migrate through the blood-brain barrier, accumulate in the central nervous system (CNS), secrete antiinflammatory cytokines and suppress production of proinflammatory cytokines of EAE and MS. Development of EAE requires coordinated expression of a number of genes involved in the activation and effector functions of inflammatory cells. Activation of inflammatory cells is regulated at the transcriptional level by several families of transcription factors. One of these is the nuclear factor kappa B ($NF{kappa}B$) family which is present in a variety of cell types and involved in the activation of immune-relative genes during inflammatory process. Since it is highly activated at site of inflammation, $NF{kappa}B$ activation is also implicated in the pathogenesis of EAE. In this study, we examined whether the inhibition of $NF{kappa}B$ activation induced by GA can have suppressive therapeutic effects in EAE mice. We observed the expression of $NF{kappa}B$ and phospho-$I{kappa}B$ proteins increased in GA-treated EAE mice compared to EAE control groups. The immunoreactivity in inflammatory cells and glial cells of $NF{kappa}B$ and phospho-$I{kappa}B$ significantly decreased at the GA-treated EAE mice. These results suggest that treatment of GA in EAE inhibits the activation of $NF{kappa}B$ and phophorylation of $I{kappa}B$ in the CNS. Subsequently, the inhibition of $NF{kappa}B$ activation and $I{kappa}B$ phosphorylation leads to the anti-inflammatory effects thereby to reduce the progression and severity of EAE. |
| Key Words:
experimental autoimmune encephalomyelitis, glatiramer acetate, $NF{kappa}B$, phospho-$I{kappa}B$ |
|
PDF Links
Full text via DOI
Download Citation
